{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:16:54Z","timestamp":1790957814174,"version":"4.1.0"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/FST\/LSI-434\/2010"],"award-info":[{"award-number":["SR\/FST\/LSI-434\/2010"]}],"id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UGC-SAP","award":["3-54\/2011"],"award-info":[{"award-number":["3-54\/2011"]}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["YSS\/2015\/001751"],"award-info":[{"award-number":["YSS\/2015\/001751"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007341","name":"Chhattisgarh Council of Science and Technology","doi-asserted-by":"publisher","award":["1124\/CCOST\/MRP\/2015"],"award-info":[{"award-number":["1124\/CCOST\/MRP\/2015"]}],"id":[{"id":"10.13039\/501100007341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007341","name":"Chhattisgarh Council of Science and Technology","doi-asserted-by":"publisher","award":["1115\/CCOST\/MRP\/2015"],"award-info":[{"award-number":["1115\/CCOST\/MRP\/2015"]}],"id":[{"id":"10.13039\/501100007341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Grant Commission","award":["MRP ID: MRP-MAJOR-PHAR-2013-31484"],"award-info":[{"award-number":["MRP ID: MRP-MAJOR-PHAR-2013-31484"]}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","award":["8-126\/RIFD\/Policy-3\/2013-14"],"award-info":[{"award-number":["8-126\/RIFD\/Policy-3\/2013-14"]}],"id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jconrel.2017.05.019","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T23:47:00Z","timestamp":1496101620000},"page":"61-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":329,"special_numbering":"C","title":["Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"260","author":[{"given":"Mukta","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ajazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulal K.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnlata","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia G.","family":"Antimisiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Mourtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Hammarlund-Udenaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.05.019_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/1061186X.2011.607499","article-title":"Ali, Nanotherapeutics for Alzheimer's disease (AD): past, present and future","volume":"20","author":"Fazil","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0015","series-title":"Quality and Costs Now and in the Future","article-title":"Improving healthcare for people living with dementia coverage","author":"Prince","year":"2016"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0020","doi-asserted-by":"crossref","first-page":"e79797","DOI":"10.1371\/journal.pone.0079797","article-title":"Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial","volume":"8","author":"Meeuwsen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0025","first-page":"e3086","article-title":"Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial","volume":"344","author":"Meeuwsen","year":"2012","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2007.10.001","article-title":"Disease-modifying therapies in Alzheimer's disease","volume":"4","author":"Salloway","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ageing\/afl063","article-title":"Advance care planning and hospital in the nursing home","volume":"35","author":"Caplan","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/jpm.2005.8.576","article-title":"A quality improvement intervention to increase palliative care in nursing homes","volume":"8","author":"Hanson","year":"2005","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0045","doi-asserted-by":"crossref","first-page":"c1345","DOI":"10.1136\/bmj.c1345","article-title":"The impact of advance care planning on end of life care in elderly patients: randomised controlled trial","volume":"340","author":"Detering","year":"2010","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/bmj.325.7356.125","article-title":"Planning for death but not serious future illness: qualitative study of housebound elderly patients","volume":"325","author":"Carrese","year":"2002","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI22317","article-title":"Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?","volume":"114","author":"Dickson","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2015.07.010","article-title":"Amyloid beta-peptide insertion in liposomes containing GM1-cholesterol domains","volume":"208","author":"Nicastro","year":"2016","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neurobiolaging.2003.12.005","article-title":"Hippocampal neurons in pre-clinical Alzheimer's disease","volume":"25","author":"West","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","article-title":"Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy","volume":"92","author":"Elias","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ics.2005.02.011","article-title":"Drug and gene targeting to the brain via blood\u2013brain barrier receptor-mediated transport systems","volume":"1277","author":"Pardridge","year":"2005","journal-title":"Int. Congr. Ser."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2016.09.003","article-title":"Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo","volume":"20","author":"Maussang","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0100","doi-asserted-by":"crossref","first-page":"320941","DOI":"10.1155\/2015\/320941","article-title":"Blood brain barrier: a challenge for effectual therapy of brain tumors","volume":"2015","author":"Bhowmik","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/nnm.16.15","article-title":"Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis","volume":"11","author":"Posadas","year":"2016","journal-title":"Nanomed. (London, England)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-3659(94)90132-5","article-title":"Drug delivery to the brain utilizing blood-brain barrier transport systems","volume":"29","author":"Terasaki","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.11.032","article-title":"Revisiting nanoparticle technology for blood-brain barrier transport: unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes","volume":"222","author":"Johnsen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0135","series-title":"Blood-to-Brain Drug Delivery Using Nanocarriers","first-page":"433","article-title":"Drug delivery to the brain \u2013 physiological concepts, methodologies and approaches","author":"PJ","year":"2014"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2016.09.017","article-title":"Saraf, Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives","volume":"241","author":"Alexander","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejpb.2014.07.005","article-title":"Polyethylene glycol (PEG)-poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications","volume":"88","author":"Alexander","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jconrel.2013.10.006","article-title":"Saraf, Poly(ethylene glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications","volume":"172","author":"Alexander","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3923\/pjbs.2013.601.609","article-title":"Biocompatible nanoparticles for sustained topical delivery of anticancer phytoconstituent quercetin","volume":"16","author":"Sahu","year":"2013","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0160","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1517\/17425247.2013.734806","article-title":"Saraf, advancement in stimuli triggered in situ gelling delivery for local and systemic route","volume":"9","author":"Ajazuddin","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10847-009-9605-y","article-title":"Encapsulation of cyclodextrin complexed simvastatin in chitosan nanocarriers: a novel technique for oral delivery","volume":"66","author":"Vyas","year":"2010","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0175","first-page":"177","article-title":"In-vitro studies of tizanidine controlled-release microcapsular matrices","volume":"19","author":"Dashora","year":"2006","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0180","doi-asserted-by":"crossref","first-page":"469679","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0190","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.plipres.2004.12.001","article-title":"Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release","volume":"44","author":"Andresen","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","article-title":"Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer","volume":"30","author":"Malam","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09687688.2010.515950","article-title":"Enzyme-triggered nanomedicine: drug release strategies in cancer therapy","volume":"27","author":"Andresen","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","article-title":"A review of stimuli-responsive nanocarriers for drug and gene delivery","volume":"126","author":"Ganta","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/NEU.0000000000000552","article-title":"Cerebral hypoperfusion-assisted intraarterial deposition of liposomes in normal and glioma-bearing rats","volume":"76","author":"Joshi","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11060-014-1584-1","article-title":"Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection","volume":"120","author":"Joshi","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-014-1421-6","article-title":"Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue","volume":"118","author":"Joshi","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0230","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1016\/j.biomaterials.2014.01.042","article-title":"Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0240","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s11095-013-1249-3","article-title":"Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies","volume":"31","author":"Markoutsa","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejpb.2012.02.006","article-title":"Anti-Abeta-MAb and dually decorated nanoliposomes: effect of Abeta1\u201342 peptides on interaction with hCMEC\/D3 cells","volume":"81","author":"Markoutsa","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0250","first-page":"94","article-title":"Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery","volume":"40","author":"Chen","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejps.2011.07.007","article-title":"Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas","volume":"44","author":"Chen","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2014.03.006","article-title":"The role of glucose transporters in the distribution of p-aminophenyl-alpha-d-mannopyranoside modified liposomes within mice brain","volume":"182","author":"Du","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJN.S23771","article-title":"Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting","volume":"7","author":"Xie","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0270","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2013.10.007","article-title":"Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes","volume":"72","author":"Qu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0275","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.2147\/DDDT.S85302","article-title":"Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study","volume":"9","author":"Salem","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11095-015-1774-3","article-title":"In vivo functional evaluation of increased brain delivery of the opioid peptide DAMGO by glutathione-PEGylated liposomes","volume":"33","author":"Lindqvist","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0285","doi-asserted-by":"crossref","first-page":"32681","DOI":"10.18632\/oncotarget.5354","article-title":"A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0290","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2174\/1568026615666150605115902","article-title":"Comparison of various types of ligand decorated nanoliposomes for their ability to inhibit amyloid aggregation and to reverse amyloid cytotoxicity","volume":"15","author":"Markoutsa","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0295","doi-asserted-by":"crossref","first-page":"24604","DOI":"10.18632\/oncotarget.8360","article-title":"Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0300","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/j.biomaterials.2014.02.031","article-title":"Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0305","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-017-0049-9","article-title":"Liposomal drug product development and quality: current US experience and perspective","author":"Kapoor","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048515","article-title":"Intravenous delivery of targeted liposomes to amyloid-beta pathology in APP\/PSEN1 transgenic mice","volume":"7","author":"Tanifum","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0325","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0330","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1359-6446(01)01721-4","article-title":"BBB-genomics: creating new openings for brain-drug targeting","volume":"6","author":"Pardridge","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp700086j","article-title":"Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability","volume":"5","author":"Dhanikula","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0340","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/jm8015409","article-title":"Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats","volume":"52","author":"Gynther","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0345","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/med.10008","article-title":"Transferrin\/transferrin receptor-mediated drug delivery","volume":"22","author":"Li","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0355","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2010.11.014","article-title":"Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain","volume":"150","author":"van Rooy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/aps.2009.199","article-title":"Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations","volume":"31","author":"Gao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0370","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1023\/A:1018982125649","article-title":"Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin","volume":"11","author":"Kang","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2006.06.001","article-title":"Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice","volume":"173","author":"Xie","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-mediated transcytosis of transferrin across the blood-brain barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0385","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s13318-015-0283-4","article-title":"A method of effectively improved alpha-Mangostin bioavailability","volume":"41","author":"Zhao","year":"2016","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0390","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuropharm.2011.09.016","article-title":"Alpha-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates beta-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation","volume":"62","author":"Wang","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0395","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.STR.0000247887.61831.74","article-title":"Blood-brain barrier genomics","volume":"38","author":"Pardridge","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0006-8993(03)03443-7","article-title":"Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies","volume":"990","author":"Omidi","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0405","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2015.10.021","article-title":"Transferrin-modified liposome promotes alpha-mangostin to penetrate the blood-brain barrier","volume":"12","author":"Chen","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0410","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jps.24081","article-title":"Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin","volume":"103","author":"Kuo","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2010.03.024","article-title":"Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis","volume":"394","author":"Tamaru","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1567201813666160204114000","article-title":"Understanding the role of poloxamer 407 based Thermoreversible in situ gelling hydrogel for delivery of PEGylated melphalan conjugate","volume":"13","author":"Alexander","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2015.06.001","article-title":"Recent approaches for reducing hemolytic activity of chemotherapeutic agents","volume":"211","author":"Jeswani","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0430","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3109\/03639045.2015.1011167","article-title":"A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates","volume":"41","author":"Alexander","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0435","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jphp.12262","article-title":"Saraf, formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate","volume":"66","author":"Alexander","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0440","doi-asserted-by":"crossref","first-page":"108101","DOI":"10.1103\/PhysRevLett.104.108101","article-title":"Cholesterol-phospholipid interactions: new insights from surface x-ray scattering data","volume":"104","author":"Ivankin","year":"2010","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0445","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0162-3109(96)00070-7","article-title":"Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system","volume":"33","author":"Bartus","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0450","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1023\/A:1018986510570","article-title":"In vitro plasma metabolism of RMP-7","volume":"11","author":"Straub","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1537-1891(02)00165-9","article-title":"Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells","volume":"39","author":"Voinea","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0460","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","article-title":"Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier","volume":"274","author":"Fillebeen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11373-006-9121-7","article-title":"Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain","volume":"14","author":"Huang","year":"2007","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0470","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-005-5371-1","article-title":"Mammalian lactoferrin receptors: structure and function","volume":"62","author":"Suzuki","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0475","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10717540601067471","article-title":"Preparation and characterization of a novel nonviral gene transfer system: procationic-liposome-protamine-DNA complexes","volume":"14","author":"Zhong","year":"2007","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0480","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/mthe.2002.0633","article-title":"Antisense gene therapy of brain cancer with an artificial virus gene delivery system","volume":"6","author":"Zhang","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0490","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","article-title":"Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery","volume":"107","author":"Lu","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0495","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2009.11.062","article-title":"Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons","volume":"1312","author":"Bottger","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0500","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.10-12-03801.1990","article-title":"Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey","volume":"10","author":"Koliatsos","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0505","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/REVNEURO.1998.9.1.31","article-title":"A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review","volume":"9","author":"Granholm","year":"1998","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.021","article-title":"Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes","volume":"298","author":"Lopez-Pinto","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0515","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.02.007","article-title":"Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin","volume":"46","author":"Wei","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0520","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1016\/j.biomaterials.2014.03.082","article-title":"Protection of SK-N-MC cells against beta-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin","volume":"35","author":"Kuo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0525","first-page":"556","article-title":"Blood-brain barrier biology and methodology","volume":"5","author":"Pardridge","year":"1999","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0530","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","article-title":"Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches","volume":"64","author":"Cardoso","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0535","series-title":"Progress in Drug Research","first-page":"39","article-title":"Structural and functional aspects of the blood-brain barrier","volume":"61","author":"Begley","year":"2003"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0540","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.biomaterials.2011.04.082","article-title":"The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells","volume":"32","author":"Cruz","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0545","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0550","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/mp800218q","article-title":"Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals","volume":"6","author":"Du","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0555","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/mp300272a","article-title":"Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study","volume":"10","author":"Lindqvist","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0560","doi-asserted-by":"crossref","DOI":"10.4155\/tde.13.38","article-title":"Therapeutic nanomedicine for brain cancer","volume":"4","author":"Tzeng","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0565","doi-asserted-by":"crossref","first-page":"e82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0570","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0006-8993(99)02184-8","article-title":"GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC","volume":"852","author":"Kannan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0575","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.08.009","article-title":"Immunoconjugates and long circulating systems: origins, current state of the art and future directions","volume":"65","author":"Koshkaryev","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0580","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0585","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.neurobiolaging.2009.11.012","article-title":"Differential recognition of vascular and parenchymal beta amyloid deposition","volume":"32","author":"Rutgers","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0590","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuroscience.2011.05.076","article-title":"Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier","volume":"190","author":"Rutgers","year":"2011","journal-title":"Neuroscience"},{"issue":"Suppl","key":"10.1016\/j.jconrel.2017.05.019_bb0595","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.nucmedbio.2014.01.009","article-title":"Biodistribution of a (67)Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag)","volume":"41","author":"Morais","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0600","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2967\/jnumed.109.070078","article-title":"Nanobodies as tools for in vivo imaging of specific immune cell types","volume":"51","author":"De Groeve","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0605","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semnuclmed.2009.12.005","article-title":"Antibody vectors for imaging","volume":"40","author":"Olafsen","year":"2010","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0610","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00259-011-2016-5","article-title":"Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging","volume":"39","author":"Rosik","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0615","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejps.2011.10.015","article-title":"Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies","volume":"45","author":"Altintas","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0620","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1476-5381.2010.00742.x","article-title":"Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours","volume":"160","author":"Iqbal","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0625","first-page":"327","article-title":"Nanobodies in therapeutic applications","volume":"9","author":"Roovers","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0630","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/1061186X.2014.888070","article-title":"Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats","volume":"22","author":"Rip","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0635","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","article-title":"Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation","volume":"164","author":"Gaillard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0640","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0645","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/tde.10.43","article-title":"Crossing barriers from blood-to-brain and academia-to-industry","volume":"1","author":"Gaillard","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0650","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.ddtec.2011.12.002","article-title":"Enhanced brain drug delivery: safely crossing the blood\u2013brain barrier","volume":"9","author":"Gaillard","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0655","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0660","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu)","volume":"34","author":"Gupta","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0665","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI114666","article-title":"Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat","volume":"85","author":"Kannan","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0670","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bbrc.1994.1715","article-title":"Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain","volume":"201","author":"Zlokovic","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0675","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0005-2736(90)90440-Y","article-title":"Liposomes for the sustained drug release in vivo","volume":"1029","author":"Blume","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0680","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0685","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/acs.molpharmaceut.5b00835","article-title":"Exploring factors causing low brain penetration of the opioid peptide DAMGO through experimental methods and modeling","volume":"13","author":"Lindqvist","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0003-2697(88)90412-5","article-title":"Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: energy transfer to nonfluorescent dimers","volume":"172","author":"Chen","year":"1988","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0695","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional liposomes reduce brain beta-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models","volume":"34","author":"Balducci","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0700","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2011.03.071","article-title":"In vivo detection of amyloid beta deposition using (1)(9)F magnetic resonance imaging with a (1)(9)F-containing curcumin derivative in a mouse model of Alzheimer's disease","volume":"184","author":"Yanagisawa","year":"2011","journal-title":"Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2017.05.019_bb0705","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0710","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1016\/j.bmcl.2011.08.003","article-title":"Synthesis and evaluation of 1-(4-[(1)(8)F]fluoroethyl)-7-(4\u2032-methyl)curcumin with improved brain permeability for beta-amyloid plaque imaging","volume":"21","author":"Lee","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0715","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nano.2012.11.004","article-title":"Curcumin-conjugated nanoliposomes with high affinity for Abeta deposits: possible applications to Alzheimer disease","volume":"9","author":"Lazar","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0720","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease","volume":"326","author":"Begum","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0725","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20025","article-title":"Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro","volume":"75","author":"Ono","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0730","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0735","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0740","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0745","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.2147\/IJN.S30919","article-title":"Neurological disorders and therapeutics targeted to surmount the blood-brain barrier","volume":"7","author":"Kanwar","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0750","first-page":"1749","article-title":"Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-beta peptide: the chemical design affects the permeability across an in vitro model","volume":"8","author":"Salvati","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0755","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Abeta aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0760","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2006.11.015","article-title":"Nerve growth factor promotes survival of new neurons in the adult hippocampus","volume":"26","author":"Frielingsdorf","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0765","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0770","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2012.12.020","article-title":"Liposomes modified with P-aminophenyl-alpha-d-mannopyranoside: a carrier for targeting cerebral functional regions in mice","volume":"84","author":"Hao","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0775","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.chroma.2009.02.028","article-title":"Interactions between local anesthetics and lipid dispersions studied with liposome electrokinetic capillary chromatography","volume":"1216","author":"Muhonen","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0780","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2014.02.016","article-title":"An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells","volume":"465","author":"Tamaru","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0785","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-4157(92)90038-C","article-title":"Sterically stabilized liposomes","volume":"1113","author":"Woodle","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0790","first-page":"146","article-title":"Uber eine eigenartige erkrankung der hirnrinde","volume":"64","author":"A","year":"1907","journal-title":"Psychiatr. Psych. Gerichtl. Med."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0795","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","article-title":"Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid","volume":"23","author":"Matsuoka","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0800","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","article-title":"Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease","volume":"295","author":"DeMattos","year":"2002","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0805","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0810","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2014.09.015","article-title":"Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-beta levels in APP\/PS1 transgenic mice","volume":"11","author":"Ordonez-Gutierrez","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0815","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.etap.2012.04.012","article-title":"Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes","volume":"34","author":"Li","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0820","doi-asserted-by":"crossref","first-page":"e112052","DOI":"10.1371\/journal.pone.0112052","article-title":"Feasibility of beta-sheet breaker peptide-H102 treatment for Alzheimer's disease based on beta-amyloid hypothesis","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0825","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.mp.4001516","article-title":"Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits","volume":"9","author":"Chacon","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0830","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0835","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000106378","article-title":"Intranasal insulin to improve memory function in humans","volume":"86","author":"Benedict","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0840","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/jps.21674","article-title":"Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake","volume":"98","author":"Vaka","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0845","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2008.04.003","article-title":"Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia","volume":"437","author":"Ma","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0850","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2011.12.008","article-title":"Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of beta-amyloid and ibotenic acid into the bilateral hippocampus","volume":"423","author":"Feng","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0855","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer's disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0860","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuro.2007.11.004","article-title":"Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells","volume":"29","author":"Ezoulin","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0865","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2006.09.087","article-title":"Changes of cholinesterase activities in the plasma and some tissues following administration of l-carnitine and galanthamine to rats","volume":"411","author":"Bajgar","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0870","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pbb.2006.08.007","article-title":"Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval","volume":"85","author":"de Bruin","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0875","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1211\/jpp.58.2.0002","article-title":"Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models","volume":"58","author":"Oh","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0880","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.10.132","article-title":"Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity","volume":"325","author":"Kihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0885","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbr.2005.04.019","article-title":"Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum","volume":"163","author":"Mulder","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0890","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(02)01235-1","article-title":"Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons","volume":"336","author":"Pan","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0895","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","article-title":"Galantamine inhibits beta-amyloid aggregation and cytotoxicity","volume":"280","author":"Matharu","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0900","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00019442-200303000-00004","article-title":"Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations","volume":"11","author":"Cummings","year":"2003","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0905","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jalz.2007.10.013","article-title":"One-week dose titration of extended release galantamine in patients with Alzheimer's disease","volume":"4","author":"Scharre","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0910","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2004.07.054","article-title":"In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract","volume":"498","author":"Turiiski","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0915","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.regpep.2007.06.012","article-title":"Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders","volume":"149","author":"Hallschmid","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0920","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0925","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2006.05.027","article-title":"Deformable liposomes and ethosomes: mechanism of enhanced skin delivery","volume":"322","author":"Elsayed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0930","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1081\/DDC-120025458","article-title":"Transfersomes\u2014a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation","volume":"29","author":"Jain","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0935","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pnpbp.2004.10.006","article-title":"Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients","volume":"29","author":"Tenovuo","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0940","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1185\/030079906X162791","article-title":"Strategies to improve tolerability of rivastigmine: a case series","volume":"23","author":"Venkatesh","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0945","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00002512-199813050-00005","article-title":"Rivastigmine. A review of its use in Alzheimer's disease","volume":"13","author":"Spencer","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0950","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","article-title":"Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration","volume":"452","author":"Yang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0955","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/ph3040961","article-title":"Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems","volume":"3","author":"Trabulo","year":"2010","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.jconrel.2017.05.019_bb0960","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpharm.2011.08.001","article-title":"Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells","volume":"419","author":"Ma","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.05.019_bb0965","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/17460441.2015.974545","article-title":"Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics","volume":"10","author":"Stanimirovic","year":"2015","journal-title":"Expert Opin. Drug Discovery"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T17:47:34Z","timestamp":1602179254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917305916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":193,"alternative-id":["S0168365917305916"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}